Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-05-08 | 109613 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2020-09-24 | 2020-10-22 | 124962 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-09-24 | 2021-01-07 | 124965 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-22 | 2021-01-07 | 126939 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128001 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128040 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-11-06 | 2021-06-03 | 128045 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132285 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132288 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140663 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140666 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-15 | 2022-02-17 | 142622 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-11-18 | 2022-01-07 | 149609 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152411 |
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2020-03-06 | 2020-06-11 | 108021 |
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2020-03-06 | 2020-06-11 | 108024 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-04-03 | 2017-10-24 | 5180 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2020-03-26 | 2021-01-28 | 109562 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |